‘Unprecedented’ demand on PBAC forces extra meeting Its capacity has been exceeded by a ‘huge pipeline of new medicines’, after companies put forward a record number of submissions.
Diabetes medication restrictions incoming More red tape is on the way after the PBAC recommended GPs gain additional approval before starting patients on Qtern 5/10.
Can medicine repurposing help GPs? Quality care experts say GPs should consider a new TGA program looking to expand prescribing criteria and medicine access, but there are caveats.
RACGP moves to shore up wavering support for 60-day dispensing Amid reports of crossbenchers becoming wary of the reform, the college has co-signed an open letter outlining the expected benefits for both patients and the primary care system.
RACGP opposes GLP-1 RA prescribing restrictions Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.
GLP-1 RA prescribing checks flagged GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.
FP 50 decision reversed GPs will once again be able to initiate PBS prescriptions for a commonly used paediatric asthma medication, following a strong advocacy campaign.
Why 60-day dispensing concerns are overblown Pharmacist-turned-GP Dr Mark Raines explains why he believes many of the measure’s criticisms are exaggerated.
PBAC to review FP 50 decision Controls placed on GPs initiating PBS prescriptions of the commonly used paediatric asthma medicine will be revisited at the next intracycle meeting.
FP 50 restriction sparks prescribing authority debate GPs have questioned why some medications can only be prescribed by certain specialties, calling differential access to the PBS ‘utterly illogical’.